New research reveals that mRNA COVID-19 vaccines may enhance the immune system's ability to fight cancer, significantly improving survival rates for patients undergoing treatment. Discover how this groundbreaking study is changing cancer care!
Merck's new injectable cancer drug, Keytruda Qlex, promises to transform patient treatment with a quick administration time and flexible dosing, all while maintaining effectiveness. Available in late September, this shift is critical as the market braces for biosimilar competition.
A groundbreaking study reveals that just one 45-minute workout can boost cancer-fighting proteins in breast cancer survivors, leading to a significant reduction in tumor growth. Learn how exercise could become a vital part of cancer treatment.
